Chongqing Zhifei Biological Products Statistics

Total Valuation

Chongqing Zhifei Biological Products has a market cap or net worth of CNY 83.14 billion. The enterprise value is 81.45 billion.

Market Cap	83.14B
Enterprise Value	81.45B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Aug 8, 2024

Share Statistics

Chongqing Zhifei Biological Products has 2.39 billion shares outstanding. The number of shares has decreased by -0.06% in one year.

Shares Outstanding	2.39B
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	59.12%
Owned by Institutions (%)	13.94%
Float	978.58M

Valuation Ratios

The trailing PE ratio is 13.78 and the forward PE ratio is 10.49.

PE Ratio	13.78
Forward PE	10.49
PS Ratio	1.78
PB Ratio	2.64
P/FCF Ratio	15.12
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.31, with an EV/FCF ratio of 14.81.

EV / Earnings	13.48
EV / Sales	1.74
EV / EBITDA	11.31
EV / EBIT	11.90
EV / FCF	14.81

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.12.

Current Ratio	2.07
Quick Ratio	1.37
Debt / Equity	0.12
Debt / EBITDA	0.54
Debt / FCF	0.71
Interest Coverage	75.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	6.34M
Profits Per Employee	820,673
Employee Count	6,545
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.35% in the last 52 weeks. The beta is 0.92, so Chongqing Zhifei Biological Products's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-37.35%
50-Day Moving Average	24.83
200-Day Moving Average	38.50
Relative Strength Index (RSI)	69.83
Average Volume (20 Days)	39,365,894

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chongqing Zhifei Biological Products had revenue of CNY 46.73 billion and earned 6.04 billion in profits. Earnings per share was 2.52.

Revenue	46.73B
Gross Profit	11.61B
Operating Income	6.85B
Pretax Income	6.95B
Net Income	6.04B
EBITDA	7.19B
EBIT	6.85B
Earnings Per Share (EPS)	2.52

Full Income Statement

Balance Sheet

The company has 5.59 billion in cash and 3.90 billion in debt, giving a net cash position of 1.68 billion or 0.70 per share.

Cash & Cash Equivalents	5.59B
Total Debt	3.90B
Net Cash	1.68B
Net Cash Per Share	0.70
Equity (Book Value)	31.53B
Book Value Per Share	13.17
Working Capital	24.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.51 billion and capital expenditures -1.01 billion, giving a free cash flow of 5.50 billion.

Operating Cash Flow	6.51B
Capital Expenditures	-1.01B
Free Cash Flow	5.50B
FCF Per Share	2.30

Full Cash Flow Statement

Margins

Gross margin is 24.85%, with operating and profit margins of 14.65% and 12.93%.

Gross Margin	24.85%
Operating Margin	14.65%
Pretax Margin	14.88%
Profit Margin	12.93%
EBITDA Margin	15.38%
EBIT Margin	14.65%
FCF Margin	11.77%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 2.19%.

Dividend Per Share	0.80
Dividend Yield	2.19%
Dividend Growth (YoY)	60.00%
Years of Dividend Growth	2
Payout Ratio	1.73%
Buyback Yield	0.06%
Shareholder Yield	2.25%
Earnings Yield	7.26%
FCF Yield	6.62%

Dividend Details

Stock Splits

The last stock split was on June 16, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 16, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Chongqing Zhifei Biological Products has an Altman Z-Score of 5.52.

Altman Z-Score	5.52
Piotroski F-Score	n/a